Publications by authors named "Tilmann Lantzsch"

Claim this Profile
P
Prospective validation of the prognostic and predictive impact of uPA/PAI-1 in early breast cancer.
Vanessa Wieder, Julia Engel, Kathleen Eichstädt, Sandy Kaufhold, Marcus Bauer, Tilmann Lantzsch

Breast Cancer Res Treat· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic and predictive impact of NOTCH1 in early breast cancer.
Julia Engel, Vanessa Wieder, Marcus Bauer, Sandy Kaufhold, Kathrin Stückrath, Tilmann Lantzsch

Breast Cancer Res Treat· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: Prognostic and predictive impact of NOTCH1 in early breast cancer.
Julia Engel, Vanessa Wieder, Marcus Bauer, Sandy Kaufhold, Kathrin Stückrath, Tilmann Lantzsch

Breast Cancer Res Treat· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic Value of Tumour-Infiltrating Lymphocytes in an Unselected Cohort of Breast Cancer Patients.
Kathleen Schüler, Daniel Bethmann, Sandy Kaufhold, Carolin Hartung, Kathrin Stückrath, Tilmann Lantzsch

Diagnostics (Basel)· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identifying High-Risk Triple-Negative Breast Cancer Patients by Molecular Subtyping.
Carolin Hartung, Martin Porsch, Kathrin Stückrath, Sandy Kaufhold, Martin S Staege, Tilmann Lantzsch

Breast Care (Basel)· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Specific allelic variants of SNPs in the and genes are associated with earlier tumor onset and progression in Caucasian breast cancer patients.
Marcus Bauer, Eva Johanna Kantelhardt, Thorsten Stiewe, Andrea Nist, Marco Mernberger, Tilmann Lantzsch

Oncotarget· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Proteomic profiling of breast cancer metabolism identifies SHMT2 and ASCT2 as prognostic factors.
Stephan Bernhardt, Michaela Bayerlová, Martina Vetter, Astrid Wachter, Devina Mitra, Tilmann Lantzsch

Breast Cancer Res· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Memory and Spatial Cognition in Breast Cancer Patients Undergoing Adjuvant Endocrine Therapy.
Ute Berndt, Bernd Leplow, Robby Schoenfeld, Tilmann Lantzsch, Regina Grosse

Breast Care (Basel)· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction of Poland's Syndrome: Case Report and Review of the Current Literature.
Tilmann Lantzsch, Dieter Lampe, Eva J Kantelhardt

Breast Care (Basel)· May 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Monitoring serum HER2 levels during neoadjuvant trastuzumab treatment within the GeparQuattro trial.
Isabell Witzel, Sibylle Loibl, Gunter von Minckwitz, Christoph Mundhenke, Jens Huober, Tilmann Lantzsch

Breast Cancer Res Treat· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reliability and validity of needle biopsy evaluation of breast-abnormalities using the B-categorization--design and objectives of the Diagnosis Optimisation Study (DIOS).
Alexander Kluttig, Pietro Trocchi, Anke Heinig, Hans-Juergen Holzhausen, Christiane Taege, Tilmann Lantzsch

BMC Cancer· June 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Polymorphisms of the endothelial nitric oxide synthase gene in breast cancer.
Lukas A Hefler, Christoph Grimm, Tilmann Lantzsch, Dieter Lampe, Heinz Koelbl

Breast Cancer Res Treat· July 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Ezrin promotes ovarian carcinoma cell invasion and its retained expression predicts poor prognosis in ovarian carcinoma.
Martin Köbel, Elise Gradhand, Katharina Zeng, Wolfgang D Schmitt, Karen Kriese, Tilmann Lantzsch

Int J Gynecol Pathol· April 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interleukin-1 and interleukin-6 gene polymorphisms and the risk of breast cancer in caucasian women.
Lukas A Hefler, Christoph Grimm, Tilmann Lantzsch, Dieter Lampe, Sepp Leodolter

Clin Cancer Res· August 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Monocyte chemoattractant protein-1 serum levels in patients with breast cancer.
Antje Lebrecht, Christoph Grimm, Tilmann Lantzsch, Elisabeth Ludwig, Lukas Hefler

Tumour Biol· July 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The correlation between immunohistochemically-detected markers of angiogenesis and serum vascular endothelial growth factor in patients with breast cancer.
Tilmann Lantzsch, Lukas Hefler, Ulf Krause, Alexandra Kehl, Christiiian Goepel

Anticancer Res· September 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expression of the von Hippel-Lindau gene protein in breast cancer tissue.
Tilmann Lantzsch, Lukas Hefler, Heinz Koelbl, Dieter Lampe

Gynecol Oncol· January 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis